Lobbying significantly shapes healthcare policy by enabling interest groups to influence legislative outcomes. Organizations such as medical associations, pharmaceutical companies, and patient advocacy groups employ lobbyists to present their perspectives and drive prioritization of specific issues. While lobbying can facilitate beneficial reforms through expert insights, it can also lead to policy skewed in favor of corporate interests rather than public health. The balance of power among these groups determines whose interests are represented in healthcare legislation, impacting access to care and the overall direction of health policy.